Dermetel
Dermatologic Disease Awareness and Teledermatology

CLINICAL TRIAL

Passed Phase I

OVER THE COUNTER NUTRITIONAL SUPPLEMENT CLINICAL TRIAL

Phase 1 is closed for recruitment. Trials took place in Seoul from March to May 2019.

Phase 2 is open for recruitment. Trials will take place in Seoul from October to December 2019. Once passed, results will be shared with the press and the public.

Phase 3 is not yet open for recruitment. Trials will take place in Seoul from February to August 2020. Once passed, results will be shared with the press and the public.

ENZYME REPLACEMENT THERAPY CLINICAL TRIAL

A major rare disease pharmaceutical company is acquiring the CRISPR-enabled ERT and will oversee all aspects of phases I to IV. The reason Dermetel has made this decision is because we are a student-run organization without the experience, time, or financial ability to oversee an extremely complex and invasive surgery trial at this time. Our new partner is a public company keen to make a difference in a patient-first, profit-second manner and this is the ideal choice for us at this time until we all graduate.

GENERAL NOTES

We hold three provisional patents, are qualifying in Seoul before transferring results to the FDA in the US, and do not wish to share any further information to the public or to the press for the time being. After we pass Phase 2 and we publish a comprehensive set of literature reviews, research papers, and clinical trial results in journals ranging from Dermatology Online Journal to JAMA Dermatology, the VP of Communications will speak to newspapers and television programs about the work we’re doing.

Please email service@dermetel.org if you seek more information. Thank you.

ACCEPTED MEDICAL JOURNALS

New England Journal of Medicine (Misha 1st Author)

JAMA Dermatology (Misha 1st author)

British Medical Journal (Misha 1st Author)

Drug Design, Development, and Therapy (Misha 1st author)

Clinical, Cosmetic, and Investigative Dermatology (Misha 1st author)

Dermatology Online Journal (Shawn and Charisma)

Drug, Healthcare, and Patient Safety (Shawn 1st author)

Open Access Journal of Clinical Trials (Shawn 1st author)

2019-forward

President: Shawn

Pre-Medical Student Leader: Charisma

Medical Student Leader: Stephanie

Professional Staff

Advisors: Misha, Alexandra, and Steve

2011-2019 Leadership Team:

Zivit Fessler, BS Biological Sciences, MS Genetic Biology, MD/PhD Pediatric Genetics 2022 - INTEGRATED PEDIATRICS and MEDICAL GENETICS

Christina Sinclair, BS Natural Sciences, MS Genetics, MD with Thesis 2019 - MATCHED DERMATOLOGY at a TOP 15 RESIDENCY!

Ida Zhang, BS Biological Sciences, JD 2019 - PHARMACEUTICAL MERGERS AND ACQUISITIONS LAW

Jonathan Sanders, BS Genetics, MS Genetics, PhD Genetics, MD with Thesis 2022 - DERMATOLOGY

Misha Kaura, AAS Fashion, BA/BS Design 2014, PhD Management 2019, LLM 2020, Ivy League JD/MBA 2022, Incoming Fulbright Scholar - ENTREPRENEURSHIP

Shawn Kaura, BS summa cum laude 2019, MPH 2020, Ivy League MD 2025, Incoming Fulbright Scholar - DERMATOLOGY